Regional cerebral glucose metabolism of patients with malignant diseases in different clinical phases
- PMID: 11257726
Regional cerebral glucose metabolism of patients with malignant diseases in different clinical phases
Abstract
Background: Psychological and psychiatric aspects of cancer patients have not been studied well in terms of functional neuroimaging. The aim of this pilot study was to investigate the relationship between regional cerebral metabolism and different clinical phases.
Material and methods: Relative cerebral glucose metabolism of 77 Japanese patients with various types of malignant diseases was studied by positron emission tomography with 18F-fluorodeoxyglucose. They were subgrouped into the 1) pre-treatment, 2) post-treatment, 3) recurrence and 4) terminal patient groups. These subgroups were compared to the control group of 17 in-patients with benign diseases, using voxel-based Statistic Parametrical Mapping software (SPM).
Results: Relative reduction in the regional cerebral metabolism was detected in the prefrontal and basolateral (inferolateral) prefrontal cortex, orbitofrontal cortex, anterior and posterior cingulate gyrus, insula, basal ganglia, hippocampus and thalamus in the pre-treatment group. The anterior and posterior cingulate gyri were hypometabolic only in the pre-treatment group. Hypometabolic areas were detected only in the basolateral prefrontal cortex, orbitofrontal cortex, ventral part of cingulate gyrus and insula in the post-treatment group. In the terminal group, the hypometabolic pattern seemed very close to that in the pre-treatment group. The results seemed to suggest that hypometabolic findings before treatments could reverse after treatments but became prominent again in terminal stages. These results do not contradict with previous epidemiological findings that high incidence of adjustment disorders was seen in earlier stages and more brain organic syndromes were seen in terminal stages.
Conclusion: It could be speculated that decreased metabolism in early stages reflects state-dependent changes and that decreased metabolism in the terminal stages reflects organic brain damages. brain of cancer patients show a fluctuation in the regional metabolism. This finding might give a suggestion that functional imaging could be used as a supplementary method for psychological evaluation of patients with severe diseases.
Similar articles
-
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.Am J Psychiatry. 2002 May;159(5):738-45. doi: 10.1176/appi.ajp.159.5.738. Am J Psychiatry. 2002. PMID: 11986126
-
Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.Arch Gen Psychiatry. 2004 Jan;61(1):73-84. doi: 10.1001/archpsyc.61.1.73. Arch Gen Psychiatry. 2004. PMID: 14706946
-
Depressive state and regional cerebral activity in cancer patients - a preliminary study.Med Sci Monit. 2001 Jul-Aug;7(4):687-95. Med Sci Monit. 2001. PMID: 11433196
-
18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.J Nucl Med. 2005 Feb;46(2):233-9. J Nucl Med. 2005. PMID: 15695781 Clinical Trial.
-
Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy.Brain. 2005 Aug;128(Pt 8):1802-10. doi: 10.1093/brain/awh534. Epub 2005 May 4. Brain. 2005. PMID: 15872014
Cited by
-
Preliminary study of brain glucose metabolism changes in patients with lung cancer of different histological types.Chin Med J (Engl). 2015 Feb 5;128(3):301-4. doi: 10.4103/0366-6999.150089. Chin Med J (Engl). 2015. PMID: 25635423 Free PMC article.
-
Regional Brain Glucose Metabolism and Its Prognostic Value in Pretreatment Extranodal Natural Killer/T-Cell Lymphoma Patients.Onco Targets Ther. 2021 May 14;14:3179-3191. doi: 10.2147/OTT.S308872. eCollection 2021. Onco Targets Ther. 2021. PMID: 34017183 Free PMC article.
-
Cerebral Structural Abnormalities and Their Associations With Peripheral Cytokine Levels in a Group of Untreated Patients With Nasopharyngeal Carcinoma.Front Oncol. 2021 Nov 26;11:740033. doi: 10.3389/fonc.2021.740033. eCollection 2021. Front Oncol. 2021. PMID: 34900691 Free PMC article.
-
Schwann cells: a new player in the tumor microenvironment.Cancer Immunol Immunother. 2017 Aug;66(8):959-968. doi: 10.1007/s00262-016-1929-z. Epub 2016 Nov 24. Cancer Immunol Immunother. 2017. PMID: 27885383 Free PMC article. Review.
-
Brian [18F]FDG PET associations of cervical cancer-related peripheral inflammatory markers.Front Oncol. 2025 Jun 26;15:1598911. doi: 10.3389/fonc.2025.1598911. eCollection 2025. Front Oncol. 2025. PMID: 40666098 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources